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Abstract
Background:  Nerve root decompression with instrumented spondylodesis is the most frequently
performed surgical procedure in the treatment of patients with symptomatic low-grade spondylolytic
spondylolisthesis. Nerve root decompression without instrumented fusion, i.e. Gill's procedure, is an
alternative and less invasive approach. A comparative cost-effectiveness study has not been performed yet.
We present the design of a randomised controlled trial on cost-effectiveness of decompression according
to Gill versus instrumented spondylodesis.
Methods/design: All patients (age between 18 and 70 years) with sciatica or neurogenic claudication
lasting more than 3 months due to spondylolytic spondylolisthesis grade I or II, are eligible for inclusion.
Patients will be randomly allocated to nerve root decompression according to Gill, either unilateral or
bilateral, or pedicle screw fixation with interbody fusion. The main primary outcome measure is the
functional assessment of the patient measured with the Roland Disability Questionnaire for Sciatica at 12
weeks and 2 years. Other primary outcome measures are perceived recovery and intensity of leg pain and
low back pain. The secondary outcome measures include, incidence of re-operations, complications,
serum creatine phosphokinase, quality of life, medical consumption, costs, absenteeism, work perception,
depression and anxiety, and treatment preference. The study is a randomised prospective multicenter trial
in which two surgical techniques are compared in a parallel group design. Patients and research nurse will
not be blinded during the follow-up period of 2 years.
Discussion: Currently, nerve root decompression with instrumented fusion is the golden standard in the
surgical treatment of low-grade spondylolytic spondylolisthesis, although scientific proof justifying
instrumented spondylodesis over simple decompression is lacking. This trial is designed to elucidate the
controversy in best surgical treatment of symptomatic patients with low-grade spondylolytic
spondylolisthesis.
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Background
Spondylolytic spondylolisthesis is an anterior slip of one
vertebral body onto another caused by a discontinuity
(lysis) of the pars interarticularis, also called the isthmus.
As a result of the pseudarthrosis, fibrocartilaginous tissue
develops at the isthmic site. Although most people with
spondylolytic spondylolisthesis are asymptomatic,
patients may present with low back pain, sciatica, neuro-
genic claudication, or a combination due to nerve root
compression in the parapedicular course under the fibro-
cartilaginous mass of the pseudo-joint, or at the neurofo-
ramen between the pedicle and slipped disc.
Treatment of patients with symptomatic spondylolytic
spondylolisthesis consists of nonsurgical management or
surgery whereby surgery yields better outcome [1]. Surgi-
cal management comprises primary reconstruction of the
pars interarticularis defect, decompression of the nerve
root without fusion, decompression with (instrumented)
spondylodesis, or a combination. Transpedicular fixation
with interbody fusion is the most frequently advocated
surgical technique [2-9].
A less invasive approach, in which nerve root decompres-
sion is performed without fusion, has been described by
Gill [10]. The operation according to Gill consists of
removing the loose lamina and excising the fibrocartilag-
inous tissue in order to decompress the nerve root. Vari-
ous studies have reported satisfactory results [11-13].
Recently, we have presented the long-term results of 42
patients treated with bilateral nerve root decompression
according to Gill or unilateral decompression; i.e. hemi-
Gill. At 11 years after surgery improvement of leg pain was
reported in 88%, and 71% documented good result in
terms of patient satisfaction [14].
Although most surgeons perform nerve root decompres-
sion with instrumented fusion in the treatment of spond-
ylolytic spondylolisthesis, scientific proof justifying
instrumented spondylodesis over simple decompression
is lacking. The clinical results of instrumented and nonin-
strumented spondylodesis seem comparable with decom-
pression according to Gill; 60 to 90% of the patients have
good results [4,6,15-20]. The main arguments that favour
intercorporal instrumented fusion are enlargement of the
neuroforamen to relieve nerve root compression, and pre-
vention of progressive slippage. Instrumented spondylod-
esis, on the other hand, constitutes major surgery with
considerable blood loss, longer operation time, and sig-
nificant complication rates which correlate with the extent
of fusion [19,21,22].
Gill's procedure is a less invasive alternative technique to
instrumented fusion. The operation time is shorter and
the paraspinal muscle injury is less extensive. Patients may
have less surgery-related low back pain and mobilise
quickly, indicating short hospitalisation, fast recovery and
early resumption to work. In addition, costs and compli-
cations related to instrumented surgery are avoided. How-
ever, secondary instrumented surgery might be necessary
in patients with recurrent or persisting leg pain due to
foraminal nerve root compression [14].
The controversy in the treatment of low grade spondylo-
lytic spondylolisthesis justifies a randomised controlled
trial comparing instrumented spondylodesis with nerve
root decompression alone. The purpose of our study, the
Sciatica-Gill trial, is to assess the clinical outcome and cost
effectiveness of both surgical strategies on the short term
(12 weeks) and long term (2 years). There will be a trade-
off between persisting or recurrent leg pain in the Gill
group and higher complication rates and costs in the
spondylodesis group. Secondly, various subgroups of
patients will be identified who may benefit primarily
from one of the allocated surgical treatments.
Methods/design
We designed a multicenter randomised controlled cost-
effectiveness trial on the treatment of low-grade spondylo-
lytic spondylolisthesis in which two surgical techniques
are compared in a parallel group design. The primary out-
come measure is the Roland Disability Questionnaire
(RDQ) for sciatica. The follow-up period will last 2 years
(with extension to 5 years). In order to collect enough
patients, a multicenter design is necessary. The study pro-
tocol is approved in all participating hospitals by the Med-
ical Ethics Committee.
We hypothesise that nerve root decompression according
to Gill is more (cost-)effective on the short term (12
weeks) and equally (cost-)effective on the long term (2
years). Equal effectiveness is defined as maximal 4 points
difference on the RDQ score between decompression and
instrumented fusion. Moreover, we will identify subgroup
of patients who may benefit more of one of the allocated
treatments.
Patients
All patients between 18 and 70 years with sciatica or neu-
rogenic claudication lasting more than 12 weeks, based
on imaging proven (MRI and CT-scan) spondylolytic
spondylolisthesis grade I or II, are eligible for this study.
During the first visit to the neurological outpatient clinic,
the patient's history will be taken and a standardized neu-
rological examination will be performed. During this visit
the surgeon will inform the patient on the pathology of
spondylolytic spondylolisthesis and controversies in best
surgical treatment for this condition. The study will be
explained to the patient and in case of a positive reaction
an appointment will be made with one of the researchBMC Musculoskeletal Disorders 2008, 9:128 http://www.biomedcentral.com/1471-2474/9/128
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nurses as soon as possible. After informed consent, the
patient will be randomised during the first visit at the
research nurse once the in- and exclusion criteria are met
(table 1). Various questionnaires, outcome measures and
baseline variables will be recorded.
Randomisation procedure
Patients will be randomly allocated to nerve root decom-
pression according to Gill, either unilateral or bilateral, or
instrumented spondylodesis. The patient, surgeon, physi-
otherapist and research nurse are not blinded for the allo-
cated treatment. Randomisation lists are prepared for
every participating hospital separately using variable sized
blocks of randomly allocated treatments to patients,
sequentially numbered in order of inclusion, to ensure
near-equal distribution of patients over the two randomi-
sations arms in the hospitals. The data manager, who is
not involved in the selection and allocation of patients,
will prepare coded, sealed envelopes containing the treat-
ment allocation. During the first visit of the research
nurse, the envelope will be opened in presence of the
patient and appointments will be made for the hospital
admission. Surgery will be performed within 6 weeks after
randomisation. Eligible patients who have a strong prefer-
ence for one of the allocated surgical techniques, and are
not willing to be randomised but are consenting to partic-
ipation in the study, will be followed as a separate cohort.
Patients, who are randomised for nerve root decompres-
sion according to Gill and have persisting leg pain on the
first follow-up moment at 12 weeks, are offered secondary
instrumented spondylodesis. These patients will be ana-
lysed in the Gill group conform the intent-to-treat princi-
ple.
Intervention
Patients will be randomised in nerve root decompression
according to Gill, unilateral or bilateral (Group A), and
decompression combined with instrumented spondylod-
esis (Group B).
(A) Decompression without spondylodesis; (hemi)Gill's procedure
A lumbosacral midline incision will be made and the par-
avertebral muscles will be dissected unilateral or bilateral,
depending on the patients' symptoms. The spondylolytic
lamina and the inferior articular process are removed,
together with fibrocartilaginous mass of the pseudo-joint.
In case of a unilateral procedure a vertical hemi-laminec-
tomy will be performed; i.e. hemi-Gill. The affected nerve
root(s) will be decompressed adequately, implicating a
reduction of the superior articular process when neces-
sary. The wound will be closed in layers with a suction
drain when necessary.
(B) Decompression with instrumented spondylodesis
The above-described bilateral decompression will be per-
formed in all patients. After performing bilateral discec-
tomy, pedicle screws will be placed in the affected
segment under fluoroscopic control. The intercorporal
space will be filled with either a cage or autologous iliac
crest, depending on the surgeon's preference. Sagittal
alignment will be achieved and the screws will be fixed to
the rods under slight compression. The wound will be
closed in layers with a suction drain when necessary.
Various surgical findings will be documented: severity of
nerve compression (none, moderate, severe, extreme),
localisation of nerve root compression (lateral recess, par-
apedicular under the pseudo-joint, neuroforamen
Table 1: Selection criteria for trial eligibility
Inclusion criteria:
• Age 18–70 years
￿ Spondylolytic spondylolisthesis grade I or II




￿ Spondylolytic spondylolisthesis grade III or IV
￿ Herniated disc on affected level, which requires discectomy
￿ Low back pain only
￿ Instability on dynamic X-ray (>3 mm)
￿ Progressive spondylolisthesis
￿ Previous surgery on affected level
￿ Extreme obesitas (BMI > 35)
￿ Severe osteoporosis/chronic use of steroids
￿ Severe comorbidity/contraindication for surgery
￿ Planned migration to another country on the short term
￿ Inadequate knowledge of Dutch language
￿ PregnancyBMC Musculoskeletal Disorders 2008, 9:128 http://www.biomedcentral.com/1471-2474/9/128
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between slipped disc and pedicle, or a combination),
aspect of the nerve root (normal, purple), aspect of the
disc (normal, bulging, protrusion, extrusion, sequester,
slipped disc), dural tear, nerve root damage, blood loss,
duration of the procedure, judgment on placement of
pedicle screws and intercorporal grafts. Postoperative time
of mobilisation and length of hospital stay will also be
documented.
Baseline data
Baseline assessment includes demographics, hobbies,
sports, work status, smoking status, back pain history,
medical history and co-morbidity, body mass index, and
neurological signs and symptoms. The patient's satisfac-
tion at work will be registered. The treatment preference of
patient, surgeon and research nurse will be assessed on a
5-point scale ranging from "strong preference for Gill's
procedure" to "strong preference for instrumented spond-
ylodesis". In any case all (clinical) outcome assessments
will also be measured at baseline as far as they are appli-
cable at that moment.
Outcome assessment
Most symptomatic patients with spondylolytic spondy-
lolisthesis report leg pain, low back pain and disability to
perform normal daily activities. We will assess the below
described validated outcome parameters. Patients will not
be informed about their previous scores. Follow-up exam-
ination will take place at 6, 12, 26, 52, 104 and 260 weeks
after randomisation. Additionally, at 3, 156 and 208
weeks after randomisation, questionnaires will be sent by
mail (table 2).
Primary outcome measure
Roland Disability Questionnaire for Sciatica (RDQ). This
illness-specific 23-item functional assessment question-
naire is frequently used for low back pain and sciatica
[23]. Scores range from 0 to 23, reflecting a simple
unweighted sum of items endorsed by the respondent.
High score reflects severe disabling pain. Recovery of pain
is defined as improvement of 11 points or more from
baseline [24]. This self-report measure of physical disabil-
ity due to low back and leg pain has shown high level of
internal consistency, construct validity, and responsive-
ness [24,25]. The RDQ is the main primary outcome
measure in this trial.
Secondary outcome measures
1) Perceived recovery
An important secondary outcome measure is perceived
recovery according to the 7-point Likert scale, ranging
from "complete recovery" to "worse than ever". This out-
come scale has been used in previous studies and appears
to be valid and responsive to change [26,27]. "Complete
recovery" and "almost complete recovery" are considered
good results. Perceived recovery will be documented by
the patient, surgeon and research nurse.
2) Visual Analogue Scale (VAS) of leg pain and low back pain
This parameter will measure the experienced pain inten-
sity in the leg and low back during the week before visiting
Table 2: Data collection and outcome measures. 
Time in weeks X03 61 22 65 21 0 4 156 208 260
Preferred treatment of patient/surgeon/RN v
Neurological examination v v v v V v v
Randomisation v
Operation v
Perceived recovery according to patient (Likert) v v vv v V v vvv
Perceived recovery according to surgeon/RN (Likert) v v v V v v
Macnab v v v v V v v
HADS v v v v V v v
Severity of complaints (VAS) v v v vv v V v vvv
Roland Disability Questionnaire v v v vv v V v vvv
Karasek v v v v V v vvv
SF-36 v v v v V v vvv
EuroQol v v v vv v V v vvv
Patient diary v v vv v V v vvv
CPK v
X-ray v v V v v
MRI v V
CT v v V
(Re)-operation v vv v V v vvv
Complications v v V v v
X is randomisation and 0 is operation. On week 3, 156, and 208 (bold columns), questionnaires will be sent by mailBMC Musculoskeletal Disorders 2008, 9:128 http://www.biomedcentral.com/1471-2474/9/128
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the research nurse. Pain will be assessed on a horizontal
100 mm scale varying from 0 mm, "no pain", to 100 mm,
"worst pain imaginable". Patients do not see the results of
earlier assessments and will score the pain experienced at
the visit. Reliability, validity and responsiveness of VAS
have been shown [28].
3) Macnab classification of surgical result
Patients will be evaluated by the surgeon and research
nurse using the Macnab classification [29] ranging from
"excellent no pain; no restriction of activity, "good; occa-
sional back or leg pain of sufficient severity to interfere
with the patient's ability to do his or her normal work, or
to enjoy leisure activity", "fair; improved functional
capacity, but handicapped by intermittent pain of suffi-
cient severity to curtail or modify work or leisure activi-
ties", and "poor; no improvement or insufficient
improvement to enable increase in activities; further oper-
ative intervention required".
4) The Short-Form 36 (SF 36)
The SF 36 is a generic health status questionnaire, which
can be easily filled out at home. It consist of 36 questions
measuring health on 8 multi-item dimensions with a
score ranging from 0 (unhealthy) to100 points (optimal
health) covering physical functioning, physical restric-
tions, emotional restrictions, social functioning, somatic
pain, general mental health, vitality, and general health
perception. This questionnaire has been used frequently
and is validated in studies on low back pain and surgery
[30,31].
5) The Karasek Job Content Questionnaire
The work perception of the patient will be assessed
according a 5-point standardized scale according to the
Karasek Job Content Questionnaire. This questionnaire is
designed to measure psychological demands, decision lat-
itude, social support, physical demands, and job insecu-
rity [32].
6) Hospital Anxiety Depression Scale (HADS)
This questionnaire consists of 7 questions concerning
depression and anxiety. The score ranges from 0 to 21. A
high score indicates more complaints: a score between 0
and 7 excludes depression and anxiety, a score between 8
and 10 suggests probable depression/anxiety, and a score
between 11 and 21 indicates depression/anxiety [33].
7) Utility measurements
The EuroQol (EQ-5D) measures 5 dimensions (mobility,
self-care, daily activities, pain/discomfort, anxiety/depres-
sion), on a 3 point scale (no, some, or extreme problems).
For each health state described by the patients, a utility
score can be calculated that reflects society's valuation of
that health state. The Dutch tariff for the EQ-5D will be
used [34]. Similarly, SF-6D utilities will be calculated
from the SF-36 profiles [35]. Whereas the EQ-5D and SF-
6D provide society's assessment of the patients' health,
the patients themselves will also assess their own health
on VAS, ranging from 0.0 (as bad as death) to 1.0 (opti-
mal health). Both the EQ-5D and the VAS will be reported
in questionnaires filled out at home.
8) Radiological examinations
Preoperatively, all patient will undergo dynamic radio-
graphs, CT and MRI. The exact slip percentage and the slip
angle will be measured on plain X-ray. The localisation of
nerve root compression (lateral recess, parapedicular
underneath pseudojoint, neuroforamen between pedicle
or slipped disc, or combination) and the amount of nerve
root compression will be quantified on MRI. We have
developed the following grading scale based on the epi-
dural fat reduction in the neuroforamen: 0–25% fat
reduction (grade 1), 25–50% fat reduction (grade 2), 50–
75% fat reduction (grade 3), and more than 75% fat
reduction (grade 4). In addition, the diameter of the neu-
roforamen will be measured on sagittal CT reconstruc-
tions. During the follow-up, dynamic X-rays, CT and MRI
will be repeated (table 2).
Other outcome measures
1) Costs
The direct medical costs of hospital admission (fixed costs
per admission, and variable costs per admission day) and
surgery (including personnel and implants) will be esti-
mated in all participating hospitals for cost-analysis.
Using cost diaries, the patients will register other medical
care (including physiotherapy, visits to general practition-
ers and medical specialists, nursing care and medication)
and non-medical costs (including out-of-pocket expenses,
domestic help and absenteeism). Each diary will cover 3
months and the research nurse will go through the diary
with the patient on every follow-up visit, throughout the
study period of 2 years. Costs will be calculated using
standard prices, including time and travel costs [36].
Absenteeism will be valued according to the friction cost
method.
2) Incidence of re-operations
In previous studies concerning spine surgery the incidence
of re-operations has been used to assess outcome. Also in
this study, we will assess the incidence of re-operation.
Every surgical re-exploration in both groups will be con-
sidered as re-operation.
3) Complications
Side effects or complications that are ascribed to the treat-
ment are recorded by the patients, their treating physi-
cians and the research nurses.BMC Musculoskeletal Disorders 2008, 9:128 http://www.biomedcentral.com/1471-2474/9/128
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4) Serum creatine phosphokinase (CPK)
Creatine phosphokinase is a known marker of muscle
damage. Previous study has demonstrated a dose-
response relation between the extend of surgery and CPK
values [37]. Therefore, we will determine the serum CPK
before surgery and 1 day after surgery in both groups.
Whether CPK is correlated with postoperative low back
pain and clinical outcome will be determined as well.
Sample size
The sample size is calculated on the basis of the RDQ both
at both short term and long term follow-up. A difference
in effectiveness is considered clinically relevant whenever
patients with nerve root decompression alone will obtain
at least 20% difference in RDQ score. Instrumented
spondylodesis is assumed to result in at least 60% good
outcome at 12 weeks. This means that 80% of the patients
treated with nerve root decompression alone should have
good results in order to proof superiority of Gill's proce-
dure. Treatment is considered to be justified in case of
improvement of at least 7 points on the RDQ score; 20%
difference corresponds to 8.4 points improvement on in
the RDQ score. With a power of 90% and a two-tailed sig-
nificance level of 0.05, 220 patients with symptomatic
spondylolytic spondylolisthesis grade I and II are needed
(110 patients in both treatment groups, including 10%
loss to follow-up). The numbers used for this sample size
calculation are retrieved from the 1 and 5-years results of
the Maine Lumbar Spine Study [38,39].
Statistical analysis
Baseline comparability will be analysed by descriptive sta-
tistics to determine whether randomisation was success-
ful. Whenever necessary to remove residual confounding
or simply in order to increase power, adjustments for
baseline variables will be performed in the analyses. Dif-
ferences in outcome measures between both groups,
together with 95% confidence intervals, will be calcu-
lated. We stipulate in advance that we will also analyze a
model containing the interaction of follow-up time and
randomisation group; if the latter is significant at the 5%
level, the conclusion of "unequality of treatments" fol-
lows; if the latter is non-significant, the treatment effect
will be calculated on the basis of a model without
group*time interaction. All data will be analysed accord-
ing to the "intention-to-treat principle". We state a priori
that we will perform as a subgroup analysis, the evalua-
tion of the interaction between the treatment allocation
and both the grading of the disease (grade I versus grade
II spondylolisthesis) as well as the localisation of nerve
root compression (underneath the pseudo-joint or
between pedicle and slipped disc). We will conclude that
the treatment effect depends on the value of those varia-
bles if the interaction is significant at the 5% level. If the
interaction is non-significant, we will quantify the main
effect of these variables in the usual way. In addition,
explorative subgroup analyses will be performed, based
on the interaction between the randomization variable
and various different baseline variables (table 3). Data
will be stored via the internet-based secure data manage-
ment system "ProMISe" of the department of Medical Sta-
tistics and Bioinformatics. The analyses will be carried out
using appropriate statistical software (e.g. SPSS).
Discussion
In this article, the rational and design of a RCT on cost-
effectiveness of two surgical strategies for sciatica caused
by low-grade spondylolytic spondylolisthesis are
described. To our knowledge this is the first RCT compar-
ing nerve root decompression according to Gill versus
instrumented spondylodesis. Based on the literature, the
clinical results of nerve root decompression alone and
instrumented spondylodesis seem equivalent, although
solid conclusions cannot be made because of various
methodological flaws.
The Sciatica-Gill trial is designed to elucidate the contro-
versy in best surgical treatment of patients with sympto-
Table 3: Selected prognostic variables for subgroup analysis
Demographic variables:
￿ Women versus men
￿ Age < 40 years versus > 40 years
￿ Smoking versus non-smoking
Anamnestic and neurological variables:
￿ Influence of back extension versus no influence
￿ Predominant low back pain versus leg pain
￿ Quetelet index < 25 versus > 25
Radiological variables:
￿ Low disc height versus high disc height
￿ Nerve root compression underneath pseudojoint versus nerve root compression between pedicle and slipped disc
￿ Grade I versus grade II spondylolytic spondylolisthesis
￿ Small cross section versus large cross section of neuroforamen
￿ Low grade versus high grade epidural fatBMC Musculoskeletal Disorders 2008, 9:128 http://www.biomedcentral.com/1471-2474/9/128
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matic spondylolytic spondylolisthesis grade I and II. Gill's
procedure is a less invasive procedure, patients can return
to work quickly and instrumented related complications
are avoided. However, secondary instrumented spondy-
lodesis might be necessary in patients with persistent or
recurrent leg pain. Currently, most surgeons advocate pri-
mary instrumented fusion. Arguments in favour of inter-
corporal spondylodesis are prevention of progressive
slippage, enlargement of the neuroforamen, reduction of
dynamic nerve root compression due to instability, and
possible influence of low back pain. Whether more inva-
sive surgery with higher costs and complications warrants
instrumented spondylodesis as primary treatment, can be
debated. Therefore we postulate that nerve root decom-
pression according to Gill is more (cost-) effective on the
short term and equally (cost-) effective on the long term,
compared to instrumented spondylodesis. Subgroup
analysis might identify patient groups who will benefit
more from one of the treatments. The inclusion period
will run until medio 2010 and follow-up measurements
will be completed in 2012.
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